Compare

Beone Medicines vs Sanofi

Beone Medicines (ONC) and Sanofi (SNY) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.

Beone Medicines ONCNASDAQ · Pharmaceutical PreparationsSanofi SNYNASDAQ · Pharmaceutical Preparations
Insider records, last 12 months130
Congress trades, last 12 months00
Fund positions reported, last 12 months2942
Federal contract awards, last 12 months00
Open-market purchases by insiders since 2006150
Open-market sales by insiders since 20061,4830
Last open-market purchase by an insiderSep 10, 2021None on record
Next resultsNot announcedNot announced

Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.

Common questions

Which has had more insider buying, Beone Medicines or Sanofi?

Since 2006, Beone Medicines insiders reported 15 open-market purchases against 0 for Sanofi, in SEC Forms 4 and 5. Counts depend on the number of insiders and how long each company has been listed.

Do members of Congress trade ONC or SNY?

In the last 12 months, members of Congress disclosed 0 trades in Beone Medicines (ONC) and 0 in Sanofi (SNY), each reported as a value range on a periodic transaction report.

When did insiders last buy ONC and SNY?

Beone Medicines: Sep 10, 2021. Sanofi: no open-market purchase on record. Dates are those of the SEC filings.

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen Beone Medicines free$9.99 a month, cancel anytime

Beone Medicines pageSanofi pageRare insider trades this weekAll comparisons

https://oqro.io/compare/onc-vs-sny